(833) 317-6278 
Eli Lilly said in a social media post Friday its weight loss drug tirzepatide had received approval from Chinese regulators, further intensifying competition with its Danish rival Novo Nordisk in the key Asian market.
Andrew Silver
Geo Focus
Coverage Attributes:
Beta
Government Announcement:
32
%
Press Release:
21
%
Legal Policy Regulation:
15
%
Cites Data:
6
%
Event Coverage:
5
%
Themes Covered:
Not enough data
Pitching Insights
Andrew Silver's coverage encompasses a wide spectrum of topics, including scientific developments, world affairs, education, finance & economy, and culture & society. His focus on government announcements and legal policy regulation suggests that he may be most responsive to pitches related to new policies or initiatives in the fields of science communication, scientific freedom, medical innovation, research collaboration as well as tech companies.
Given the diversity of themes covered within his articles along with substantial government announcement coverage (41%), Andrew might be interested in receiving pitches from experts who can provide insights into how national governments are shaping these areas. This could include individuals involved in advocacy groups or think tanks focused on relevant issues such as science communication and international cooperation.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Journalists With Similar Coverage:
Based on similarity of content.
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
